In patients with drug-induced hemolytic anemia, the preferred treatment is discontinuation of the drug. Other drugs may be substituted.
A positive DAT does not indicate that drug therapy should be stopped, especially if the drug is therapeutically beneficial and significant hemolysis is not present. If hemolytic anemia is not present, continuation of drug therapy is an option.
